Impel LOGO.png
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering
April 22, 2021 18:48 ET | Impel NeuroPharma
SEATTLE, April 22, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (Impel), a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize...